Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
299
-
Total 13F shares, excl. options
-
54.6M
-
Shares change
-
+1.48M
-
Total reported value, excl. options
-
$8B
-
Value change
-
+$210M
-
Put/Call ratio
-
2.29
-
Number of buys
-
146
-
Number of sells
-
-143
-
Price
-
$146.25
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q3 2017
372 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q3 2017.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 299 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.6M shares
.
Largest 10 shareholders include PUTNAM INVESTMENTS LLC (8.28M shares), FMR LLC (8.04M shares), VANGUARD GROUP INC (4.74M shares), BlackRock Inc. (2.88M shares), JPMORGAN CHASE & CO (1.67M shares), Bank of New York Mellon Corp (1.49M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1.44M shares), Senator Investment Group LP (1.3M shares), RENAISSANCE TECHNOLOGIES LLC (1.22M shares), and Viking Global Investors LP (1.2M shares).
This table shows the top 299 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.